AdipoLABs successfully cooperates in medical tourism with Sichuan Province, China

Accelerate project progress by providing an in-depth exchange platform and promote the prosperity of the medical tourism industry in both countries

[Medical Newspaper/Daily Newspaper = Reporter Oh In-gyu] AdipoLABs (CEO Sung-ho Han), a domestic cancer treatment device manufacturer, announced on the 26th that it had recently successfully carried out medical tourism cooperation with Sichuan Province, China, for a 4-day, 3-night schedule.

(Center of photo) CEO Han Sung-ho is signing an agreement to promote the development of the Korea-China medical tourism business.

The itinerary of CEO Han Sung-ho's personal visit consisted of a visit to the Elderly Association of Chengdu, Sichuan Province, a visit to Sichuan Yui Hospital, an exchange with the Chengdu Cancer Association, and a Korea-China medical tourism seminar.

The Korea-China medical tourism seminar, which became a particular highlight, is a cooperation platform for companies to promote Korea-China medical tourism cooperation as companies are actively seeking cooperation opportunities to promote the development of the medical tourism industry in both countries as interest in Korea-China medical tourism cooperation has recently increased. The goal is to promote the prosperity of the medical tourism industry in both countries by providing and accelerating the progress of the project. The visit has received great attention.

Based on this, parties will promote in-depth exchanges and project cooperation between Korean and Chinese medical tourism companies and jointly discover new areas of business cooperation.

Through the introduction of corporate projects, attendees were able to gain a more comprehensive understanding of the latest development trends, project characteristics, and advantages of the Korean-Chinese medical tourism industry.

AdipoLABs key officials visited Sacheon Yui Hospital

CEO Han Sung-ho said, “We will strengthen cooperation and partnerships between Korean and Chinese medical tourism-related companies and promote joint development through processes such as negotiation, exchange, and MOU signing.”

Meanwhile, AdipoLABs is a specialized manufacturer of hyperthermia cancer treatment devices and obesity equipment using high frequency. It develops, manufactures, and sells medical, personal, and home medical devices based on high frequency core technology and creative ideas thanks to its pure domestic technology.

The representative device, REMISSION 1℃, is a medical device that can relieve pain through deep heat by raising body temperature above 40℃. Hyperthermia is widely used in cancer treatment due to its effectiveness in improving blood circulation and immunity. Distribution began in Korea in 2019. About 80 medical institutions, including Seoul St. Mary's Hospital of the Catholic University of Korea, are using REMISSION 1℃. The company received permission from the Ministry of Food and Drug Safety in 2015, and FDA and Halal certification in 2018.

출처 : 아디포랩스, 중국 쓰촨성과 의료관광 협력 성공적 진행 < 의료기기·IT < 기사본문 - 의학신문 (bosa.co.kr)

Source: AdipoLABs successfully cooperates in medical tourism with Sichuan Province, China < Medical devices/IT < Text of article - Medical Newspaper (bosa.co.kr)